You guys don't think you might be calling it a touch too early? The resistance at 11 wasn't exactly proven and the market depth at .10c of more than 250k is still a hurdle.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025